Scopus Biopharma Inc. (SCPS) Social Stream
SCOPUS BIOPHARMA INC (SCPS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SCPS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-18 | 1 | $20 | $20 | $20 | $0.168 | 11804.76% |
Price Target Last Issued June 18, 2021
The Trend in the Analyst Price Target
SCPS's average price target has moved down $0 over the prior 94 days.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
SCPS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how SCOPUS BIOPHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- To contextualize these metrics, consider that out of all US stocks, SCOPUS BIOPHARMA INC's variance in analysts' estimates is lower than nearly 100% of them.
- SCPS has a greater upside potential (average analyst target price relative to current price) than 99.72% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, SCOPUS BIOPHARMA INC's average analyst price target is greater than 78.51% of them.
Stocks similar to SCOPUS BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VIRI, IPA, and QLI.
View All Top Stocks by Price Target
Is SCPS a Buy, Hold or Sell? See the POWR Ratings now!